OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
299
Results
Show all
Save search
Copy query
Show results for
Unknown
(270)
Genomics
(19)
Transcriptomics
(9)
Metabolomics
(1)
Organisms
Homo sapiens
(23)
Ovis aries
(2)
synthetic construct
(1)
Repository
EGA
(18)
biostudies-arrayexpress
(10)
MetaboLights
(1)
Disease
T. circumcincta infection
(1)
Normal
(1)
Technology Type
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0
(1)
Affymetrix 6.0
(1)
Illumina 1.2M, Affymetrix 6.0
(1)
NMR spectroscopy
(1)
Instrument Platform
Illumina Genome Analyzer II
(1)
Illumina HiSeq 2500
(1)
Nuclear Magnetic Resonance (NMR) -
(1)
Publication Date
2013
(4)
2024
(2)
2011
(2)
2015
(1)
2012
(1)
2021
(1)
CHEBI ID
CHEBI:1148
(1)
CHEBI:15344
(1)
CHEBI:15354
(1)
CHEBI:15366
(1)
CHEBI:15428
(1)
CHEBI:15603
(1)
CHEBI:15611
(1)
CHEBI:15891
(1)
CHEBI:15971
(1)
CHEBI:16024
(1)
CHEBI:16236
(1)
CHEBI:16344
(1)
CHEBI:16347
(1)
CHEBI:16414
(1)
CHEBI:16643
(1)
CHEBI:16737
(1)
CHEBI:16857
(1)
CHEBI:16919
(1)
CHEBI:16977
(1)
CHEBI:17170
(1)
CHEBI:17191
(1)
CHEBI:17196
(1)
CHEBI:17203
(1)
CHEBI:17268
(1)
CHEBI:17295
(1)
CHEBI:17301
(1)
CHEBI:17549
(1)
CHEBI:17634
(1)
CHEBI:17754
(1)
CHEBI:17824
(1)
Metabolite Name
2-Hydroxybutyric acid
(1)
3-Hydroxybutyric acid
(1)
3-Hydroxyisovaleric acid
(1)
5-Aminolevulinic acid
(1)
Acetic acid
(1)
Acetoacetic acid
(1)
Choline
(1)
Citric acid
(1)
Creatine
(1)
Creatinine
(1)
D-Glucose
(1)
D-Mannose
(1)
Dimethylamine
(1)
Ethanol
(1)
Formic acid
(1)
Glucaric acid
(1)
Glycerol
(1)
Glycerophosphocholine
(1)
Glycine
(1)
Guanidoacetic acid
(1)
Isopropyl alcohol
(1)
L-Alanine
(1)
L-Asparagine
(1)
L-Carnitine
(1)
L-Glutamine
(1)
L-Histidine
(1)
L-Isoleucine
(1)
L-Lactic acid
(1)
L-Leucine
(1)
L-Lysine
(1)
Study type
Transcription profiling by array
(4)
Comparative genomic hybridization by array
(2)
RNA-seq of coding RNA
(2)
Other
(1)
DNA-seq
(1)
Release Date
2023
(32)
2021
(30)
2024
(29)
2025
(28)
2020
(26)
2022
(24)
2018
(22)
2019
(20)
2017
(13)
2016
(13)
2013
(12)
2015
(10)
2014
(9)
2026
(4)
2011
(3)
2012
(2)
2010
(2)
2009
(1)
Previous
page
1 / 30
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
30
Next
page
Sort
by:
Relevance
Page size
10
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Not available
S-EPMC10891443
|
biostudies-literature
Cite
Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.
Not available
S-EPMC4533988
|
biostudies-literature
Cite
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
Not available
S-EPMC5396533
|
biostudies-literature
Cite
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.
Not available
S-EPMC7973128
|
biostudies-literature
Cite
Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies.
Not available
S-EPMC7446411
|
biostudies-literature
Cite
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Not available
S-EPMC6340722
|
biostudies-literature
Cite
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.
Not available
S-EPMC5657013
|
biostudies-literature
Cite
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Not available
S-EPMC10964523
|
biostudies-literature
Cite
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy.
Not available
S-EPMC11976493
|
biostudies-literature
Cite
Clinical development and management of adverse events associated with FGFR inhibitors.
Not available
S-EPMC10591034
|
biostudies-literature
Cite
Previous
page
1 / 30
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
30
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
